Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules EP News Bureau Nov 13, 2025 Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…
Alembic Pharmaceuticals receives USFDA approval for Macitentan Tablets, 10 mg EP News Bureau Aug 19, 2025 Alembic Pharmaceuticals secures final approval for its ANDA Macitentan Tablets, a therapeutic equivalent of Actelion’s Opsumit,…
Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection EP News Bureau Jun 30, 2025 Alembic secures final US FDA approval for generic version of Doxil Liposome Injection used in ovarian cancer, AIDS-related…
